STAND. COM. REP. NO.3089
RE: S.C.R. No. 65
Honorable Robert Bunda
President of the Senate
Twenty-First State Legislature
Regular Session of 2002
State of Hawaii
Your Committee on Health and Human Services, to which was referred S.C.R. No. 65 entitled:
"SENATE CONCURRENT RESOLUTION SUPPORTING CONGRESSIONAL ENACTMENT OF MEDICARE COVERAGE OF ORAL CANCER DRUGS,"
begs leave to report as follows:
The purpose of this measure is to support Congressional enactment of Medicare coverage of oral anti-cancer drugs.
Your Committee received testimony in support of the measure from a Maui County Council member, National Patient Advocate Foundation, and American Cancer Society.
Your Committee finds that, although there has been strong bipartisan support in Congress to pass legislation requiring Medicare to cover oral anti-cancer medications, an urgent push is needed from the states. If Congress intended for patients to receive treatment for cancer there is no reason not to include oral treatments, especially as it has been estimated that within the next ten years 25% of cancer drug therapy will be administered orally.
As affirmed by the record of votes of the members of your Committee on Health and Human Services that is attached to this report, your Committee concurs with the intent and purpose of S.C.R. No. 65 and recommends its adoption.
Respectfully submitted on behalf of the members of the Committee on Health and Human Services,
DAVID MATSUURA, Chair